Status:
COMPLETED
Botulinum Toxin in the Treatment of Gingival Smile
Lead Sponsor:
Universidade Ibirapuera
Conditions:
Smiling
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Objective: to evaluate the effect of two gingival smile treatment techniques using botulinum toxin. Materials and methods: The randomized, double-blind clinical trial (patient and examiner) will be co...
Eligibility Criteria
Inclusion
- Patients of both genders exhibiting gingival exposure greater than or equal to 3 mm above the central incisor during smile
- Patients with good general health and good oral hygiene.
Exclusion
- Patients with Botulinum Toxin allergy or albumin, or who have previously performed botulinum toxin facial treatment previously.
- Patients with Amyotrophic Lateral Sclerosis, Neuropathy, Myasthenia Gravis or Lambert-Eaton Syndrome, women who are pregnant or planning to become pregnant, are breastfeeding women.
- Patients who are participating in other research involving other drugs.
- Patients who use drugs that interfere with neuromuscular transmission
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03812965
Start Date
August 1 2018
End Date
April 8 2019
Last Update
June 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Ibirapuera
São Paulo, São Paulo, Brazil, 04661-100